GLP 1 Diabetes 40% carbs, 35% protein & 25% fat Calorie Ranges 1200, 1400, 1600, 1800 Creator: Suzanne Fisher, LD RD The GLP-1 Diabetes meal plans were developed to maintain glycemic stability among individuals diagnosed with non-insulin dependence who are prescribed GLP-1 medication
Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M, et al
75% of US consumers say GLP-1s are a useful tool, not a magic cure - but 61% of users admit it can feel like cheating. The stigma is fading fast
All opinions shared are my own
Clinical Trial Results STEP Trials (Semaglutide) The STEP program studied semaglutide 2.4 mg weekly in overweight/obese adults: STEP 1 : 16.9% average weight loss over 68 weeks vs 2.4% placebo STEP 2 (T2D patients): 9.6% weight loss STEP 3 (with behavioral therapy): 16.0% weight loss STEP 5 (2-year data): 15.2% sustained weight loss SURMOUNT Trials (Tirzepatide) The SURMOUNT program studied tirzepatide at 5mg, 10mg, and 15mg weekly: SURMOUNT-1 : 20.9% average weight loss at 15mg over 72 weeks vs 3.1% placebo SURMOUNT-2 (T2D patients): 14.7% at 15mg SURMOUNT-3 (with lifestyle intervention): 26.6% at highest dose SURMOUNT-4 (maintenance): continued weight loss vs weight regain on placebo Head-to-Head No large head-to-head trial has directly compared them at optimal doses for weight loss
PMID 9546215